Xillix Technologies Corp (XLX.TO) Buy, Sell…

Home

Daily Stock Opinions and Ratings

Xillix Technologies Corp (XLX.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.00

-0.00 (0.00%)

0 watching

DON'T BUY

Small market cap of $15 million. Sales have not been as good as expected. Expected loss of $.04 in earnings in 2007.

DON'T BUY

Have got approval from FDA. Estimates have gone down the last 90 days because they hired a large sales staff, but sales are not appearing as quickly as hoped. Earnings are expected to get better for Dec/06, but are still negative going from -$0.08 to -$0.05. Looking out to ’07, they are expecting to earn $0.01.

DON'T BUY

Has interesting technology that uses flourescent lighting to look inside the lungs re: early stage cancer. Ranks 678 out of 700 in the database, the bottom 10%. The market is waiting for sales to appear.

WAIT

Have the FDA approval. The challenge in the recent quarter is that sales have been almost non-existant. Now ramping up their sales force which will be an increase in expenses. An excellent product, but a "wait and see" stock. Earnings may take a year, if not longer.

TRADE

Waiting for the FDA approval and are fairly confidant they are going to get it. Just signed a marketing agreement with Conmed (CNMD-Q) which is an expert on high tech medical equipment. These 2 things should be a great impetus to put this company considerably higher.

DON'T BUY

Did a financing and have some cash. Earnings estimates are for losses, $0.06 in 2005 and $0.02 in 2006. Estimates have been shaved down by about 10% in the last 90 days. Next earnings are due to be reported in 2 weeks. Great product, but still waiting for approval.

BUY

Have a product for finding colon/lung cancer. The innovation in terms of product will be adopted by the industry.

HOLD

Hoping to get the FDA pre-market approval very soon and will be able to offer their flourescent device for early lung cancer detection. Interesting speculation.

WAIT

Interesting technology. They use white light, which is the conventional lighting, for looking inside the body, but also their proprietory flourescent lighting. The challenge is that the company is expected to burn a bunch of cash. Will wait for the sales to start and earnings start to turn.

BUY ON WEAKNESS

Sold his position for tax loss reasons in December. Would like to get back in at around $0.70/0.75. A terrific company. Likes their technology. If they get FDA approval, he would expect a price of $1.85/2.00 in 12/24 months.

HOLD

FDA gave a pass to proceed with the testing of Onco-Life, so not sure why the stock has not moved. Still likes.

TRADE

It is special and interesting stock.

DON'T BUY

Has interesting technology. Ranks borderline 25% bottom part of the database. Earnings loss of $.11 improved to a loss of $.07 in 04 and $.02 for 05. Wait for FDA approval.

WEAK BUY

Intermediate buy signal. Has interesting technologies. Speculative.

BUY

Expect there will be some news out in the next 3/6 months. Good technology. A viable business.

Showing 1 to 15 of 28 entries

Xillix Technologies Corp (XLX.TO) Frequently Asked Questions

What is Xillix Technologies Corp stock symbol?

Xillix Technologies Corp is a OTC stock, trading under the symbol XLX.TO (previously XLX-T on Stockchase) on the undefined (undefined). It is usually referred to as or XLX.TO

Is Xillix Technologies Corp a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on XLX.TO (previously XLX-T on Stockchase) on Stockchase. Read the latest expert commentary for Xillix Technologies Corp.

Is Xillix Technologies Corp a good investment or a top pick?

Xillix Technologies Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Xillix Technologies Corp.

Why is Xillix Technologies Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Xillix Technologies Corp.

Is Xillix Technologies Corp worth watching?

Xillix Technologies Corp is covered by Stockchase experts and is worth watching.

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Xillix Technologies Corp (XLX.TO)